Immunocore Holdings: Peers

The FY2025 (Dec) proxy of Immunocore Holdings names 20 peer companies for pay. Among Immunocore Holdings and these peers, CEO pay was 4th highest of 7 and total shareholder return was 4th highest of 7.

4th highest of 7in Immunocore Holdings and its pay peers, FY2025 (Dec) by CEO pay:

$5.8M$25.6M

4th highest of 7in Immunocore Holdings and its pay peers, FY2025 (Dec) by total shareholder return:

$23$247

Pay peer group, FY2025 (Dec) proxy

TG Therapeutics
Revolution Medicines
Ionis Pharmaceuticals
IDEAYA Biosciences
Vir Biotechnology
Beam Therapeutics
Amicus TherapeuticsNot disclosedNot disclosed
Apellis PharmaceuticalsNot disclosedNot disclosed
Arcus BiosciencesNot disclosedNot disclosed
Arrowhead PharmaceuticalsNot disclosedNot disclosed
ArvinasNot disclosedNot disclosed
Axsome TherapeuticsNot disclosedNot disclosed
Bicycle TherapeuticsNot disclosedNot disclosed
Blueprint MedicinesNot disclosedNot disclosed
Galapagos NVNot disclosedNot disclosed
ImmaticsNot disclosedNot disclosed
Intra-Cellular TherapiesNot disclosedNot disclosed
Legend BiotechNot disclosedNot disclosed
Mirium PharmaceuticalsNot disclosedNot disclosed
XencorNot disclosedNot disclosed
20 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.